Samantha McLemore
Net buyingPatient Capital Management, LLC — managed by Samantha McLemore; US equity positions disclosed quarterly via SEC 13F
Data as of 2026-03-31 (filed 2026-05-14) · Source: SEC EDGAR
Patient Capital Management, LLC's most recent 13F filing, for the quarter ended 2026-03-31, reports 40 positions worth $2.74B. The top 5 holdings represent 28% of that value, a broadly diversified portfolio.
The single largest position is Royalty Pharma Plc at 6.4% of the portfolio, followed by Citigroup Inc at 5.9% and Alphabet Inc at 5.6%.
Against the prior quarter, Samantha McLemore opened 4 new positions, exited 4, added to 23, and trimmed 11. The largest new buy was Adobe Inc. The most notable sale was the full exit from Mattel Inc.
Across all 8 quarters on file, Royalty Pharma Plc has appeared in every filing, as has Citigroup Inc. Royalty Pharma Plc currently ranks first by value.
A 13F is filed roughly 45 days after quarter-end and covers only long positions in US-listed equities, so it is a lagging and partial view of the portfolio. Source: SEC EDGAR.
None of Samantha McLemore's tracked holdings are in the strike zone right now.
Valuation as of 2026-07-02; method: conservative Greenwald value band + Owner-Earnings DCF. Position observation, not advice.
Next · is it cheap
Samantha McLemore has no positions in the strike zone right now.
Browse the whole market by value band- Value$174.8MValuation—Holders2Weight (prev→now)5.0% → 6.4% ▲
- Value$160.3MValuationAbove valueHolders9Weight (prev→now)5.8% → 5.9% ▲
- Value$153.6MValuationAbove valueHolders34Weight (prev→now)7.0% → 5.6% ▼
- Value$136.3MValuationAbove valueHolders31Weight (prev→now)5.0% → 5.0% ▲
- Value$131.6MValuation—Holders3Weight (prev→now)4.8% → 4.8% ▲
- Value$124.0MValuationAbove valueHolders17Weight (prev→now)4.6% → 4.5% ▲
- Value$118.3MValuationAbove valueHolders14Weight (prev→now)4.7% → 4.3% ▲
- Value$117.5MValuation—Holders4Weight (prev→now)3.4% → 4.3% ▲
- Value$108.1MValuation—Holders3Weight (prev→now)3.6% → 4.0% ▲
- Value$107.5MValuation—Holders4Weight (prev→now)4.6% → 3.9% ▲
- Value$97.9MValuation—Holders1Weight (prev→now)2.7% → 3.6% ▲
- Value$97.9MValuationAbove valueHolders27Weight (prev→now)3.6% → 3.6% ▲
- Value$97.5MValuationAbove valueHolders12Weight (prev→now)3.8% → 3.6% ▲
- Value$75.2MValuationAbove valueHolders1Weight (prev→now)1.6% → 2.7% ▲
- Value$72.3MValuationAbove valueHolders10Weight (prev→now)New · 2.6%
- Value$70.0MValuationAbove valueHolders7Weight (prev→now)2.5% → 2.6% ▲
- Value$69.6MValuationAbove valueHolders2Weight (prev→now)3.9% → 2.5% ▼
- Value$69.0MValuation—Holders1Weight (prev→now)3.0% → 2.5% ▼
- Value$67.4MValuation—Holders3Weight (prev→now)2.8% → 2.5% ▲
- Value$67.1MValuation—Holders3Weight (prev→now)2.9% → 2.5% ▼
- Value$66.1MValuation—Holders2Weight (prev→now)1.4% → 2.4% ▲
- Value$55.5MValuationAbove valueHolders8Weight (prev→now)2.4% → 2.0% ▼
- Value$54.0MValuationBelow value· unconf.Holders7Weight (prev→now)0.7% → 2.0% ▲
- Value$54.0MValuation—Holders3Weight (prev→now)2.0% → 2.0% ▲
- Value$48.5MValuation—Holders3Weight (prev→now)2.1% → 1.8% ▲
Showing top 25 of 40 positions
Sources· SEC EDGAR 13F as of 2026-03-31 · filed 2026-05-14
Stay Updated
Curated 13F moves and valuation insights, straight to your inbox.